Uncategorized

Australia’s research and development landscape is about to change in a big way. The Australian Government has kicked off an independent strategic examination of research and development to overhaul how the country supports innovation. Final recommendations are due by 31 December 2025. For founders, CFOs and emerging sectors like AI and biotech, what happens next … Read more

Here’s an interesting contradiction: the Reserve Bank of Australia has cut interest rates twice in 2025, bringing the cash rate down to 3.60%. That should mean more investment, right? Not quite. According to the RBA’s August 2025 Statement, business investment is actually expected to flat-line through 2025–26. As a result, most companies are hitting pause … Read more

Pharmaceutical innovations play a vital role in transforming healthcare, advancing medical research, and boosting economic growth. From groundbreaking drug discoveries to advancements in biotechnology, Australia’s pharmaceutical sector is evolving rapidly, driven by cutting-edge research, technological advancements, and government support. This article dives into the key trends, challenges, and opportunities shaping pharmaceutical innovations in Australia and … Read more

The R&D Tax Incentive (R&DTI) is one of Australia’s most generous innovation funding mechanisms. For any startup company focused on building something new, whether a product or service, it can be the difference between stretching your runway or stalling out too soon. But while the rebate is designed to support growth, startup mistakes around timing, … Read more

Funding is one of the most critical decisions a founder or CFO will make. The type of capital you raise affects not just your balance sheet, but your ownership, control, and long-term valuation. Yet, in the rush to extend runways or fuel growth, many businesses jump into a raise without fully considering the trade-offs. Understanding … Read more

The pharmaceutical industry is under growing pressure to adopt sustainable practices, and for good reason. From high energy consumption to water pollution, drug development and manufacturing have long taken a toll on the environment. As regulations tighten and consumer expectations shift, companies are being forced to rethink how they operate. However, sustainability efforts require significant … Read more

Medical innovations are transforming healthcare—faster drug discovery, smarter manufacturing, and more personalised care. The future is bright for those ready to push boundaries. From AI-driven breakthroughs to sustainable production, innovators are transforming the industry. But big ideas need the right support to succeed. In this article, we explore the major challenges pharmaceutical companies face, the … Read more

Innovation is the engine that drives business growth. Yet too often companies stall at the funding stage, mistakenly believing that traditional investment paths are the only way forward. This misconception, what we call the investment fallacy, can prevent businesses from tapping into more suitable, faster funding solutions like R&D financing. If you are building something … Read more

Research and development (R&D) is often perceived as something that only happens in high-tech labs or cutting-edge startups. But in reality, eligible R&D activities take place across a wide range of industries, from agriculture to software development. If your business is developing new or improved products, processes or services, there’s a good chance you’re undertaking … Read more

Accessing funding to fuel your business’s growth can often feel like navigating a maze. But if you’re investing in research and development (R&D), you may already be on the right track to unlocking early-stage funding through R&D finance. Before diving in, it’s important to understand the connection between R&D finance and the R&D Tax Incentive, … Read more